Bruker Corporation (BRKR) vs Penumbra, Inc. (PEN)
- Bruker Corporation BRKR 61.20 +5.41%
- Penumbra, Inc. PEN 319.20 −0.59%
Bruker Corporation and Penumbra, Inc. are both Medical Devices companies. Penumbra, Inc. is the larger, with a market value of $12.7B against $8.9B — 1.4× the size. Bruker Corporation has negative trailing earnings, so its P/E is not meaningful; Penumbra, Inc. trades at 79.9×. Penumbra, Inc. grew revenue faster over the last twelve months: 17.0% against 2.16%. Penumbra, Inc. has the higher net margin (10.1% vs −4.76%) and the higher return on invested capital (12.7% vs −1.12%). Across the 20 metrics below, Penumbra, Inc. leads on 15 and Bruker Corporation on 5.
Valuation
Profitability
| Metric | BRKR | PEN | Medical Devices median |
|---|---|---|---|
| Gross margin | 47.66% | 67.98% | 57.76% |
| Operating margin | (1.99%) | 12.13% | (14.84%) |
| Net margin | (4.76%) | 10.06% | (14.45%) |
| Free cash flow margin | 6.97% | 12.84% | (5.70%) |
| Return on equity | (7.04%) | 10.67% | (10.56%) |
| Return on assets | (2.73%) | 8.33% | (17.26%) |
| Return on invested capital | (1.12%) | 12.73% | (5.22%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack